Chronic Obstructive Pulmonary Disease, COPD
Conditions
Keywords
COPD, Chronic Obstructive Pulmonary Disease, Formoterol Fumarate, Formoterol
Brief summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug
Interventions
DRUGFormoterol Fumarate
Sponsors
Dey
Study design
Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
5 Years to 70 Years
Healthy volunteers
No
Inclusion criteria
* Diagnosis of COPD * History of cigarette smoking
Exclusion criteria
* Clinical diagnosis of asthma * Significant pulmonary disease other than COPD * Other significant major organ disease(s)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Measure of lung function | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in lung function, as well as vital signs | — |
| Physical Exam results, adverse event reporting, etc | — |
Countries
United States
Outcome results
None listed